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Purpose: To quantify and characterize dolichol species in cataractous and clear human lenses.
Methods: Whole lenses were collected from cadaver eyeballs from the C.H. Nagri Eye Bank and Red Cross Society Eye
Bank (Ahmedabad, India). Cataractous nuclei were collected after extracapsular cataract extraction (ECCE). Wet weight
for all  the lenses was taken and were stored at –50 °C until  used.  Dolichol was extracted  using a  standard  protocol  and
then analyzed using High  Performance  Liquid  Chromatography (HPLC) on  a 4.6 mm×60  mm Hypersil-Octadecylsilane 
(ODS; 3 μm)  reversed  phase  column  using a  Waters  dual pump apparatus, a Waters gradient programmer, and an
ultraviolet  (UV)  detector  set at  210 nm.  Dolichol 13  was used as an  internal standard, and dolichol mixture from the
liver was used as an external qualitative standard.
Results: The highest dolichol concentration was found in nuclear cataract (2.54±0.6 μg) followed by posterior subcapsular
cataract (1.4±0.35 μg), and the lowest levels were observed in cortical cataract (0.37±0.06 μg). The level  of  dolichol
concentration in cataractous lenses was statistically significantly higher than the levels in clear lenses (1.0±04.3 μg;
p<0.01).
Conclusions: The dolichol concentration was significantly higher in lenses with nuclear cataract. A significant difference
in dolichol concentration was observed between the different types of cataract. It suggests that dolichol and other
isoprenoids may be associated with cataractogenesis.
Dolichols are long chains of hydrophobic lipids broadly
distributed in all tissues and cellular membranes of eukaryotic
cells [1]. The biological role of phosphorylated dolichols as
cofactors in the biosynthesis of glycoproteins is well
characterized [2]. Dolichols are also postulated to serve as
donors of isoprenoid groups during protein prenylation.
Biophysical studies have shown that dolichols exert an effect
on the permeability and fluidity of model membranes [3]. In
line with this observation was the finding that dolichol is
involved in the transport of the endoplasmic reticulum (ER)
and vacuolar proteins in yeast [4]. With reference to the
locations and stoichiometry of polyunsaturated fatty acids
(PUFA), dolichol and vitamin E, it is proposed that these
molecules interact with each other to form a highly matched
free radical transfer chain whose malfunctioning could be
involved in statin toxicity and neurodegenerative diseases
[5]. Hence, dolichol most probably affects the structure and
fluidity of the cellular membrane and consequently has an
influence on the activity of membrane-associated proteins. It
also seems plausible to presume that dolichol protects the
components of biological membranes against oxidative stress
[5]. Dolichol has also been shown to delay the G1 cell cycle
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arrest in human fibroblasts [6]. On the other hand, plant
isoprenoids have been shown to initiate apoptosis and cell
cycle arrest in murine tumor cells, which in turn suppress the
growth of the tumor [7]. The isoprenoid-mediated induction
of detoxifying activities and the antioxidant activity of some
plant isoprenoids is well recognized [8]. Thus, dolichol seems
critical for many important events in cellular life.
The lens, an encapsulated structure, consists of a large
number of elongated cells also known as fiber cells. They are
produced via terminal differentiation of a monolayer of
epithelial cells lining the anterior lens capsule. During
terminal differentiation, fiber cells lose all subcellular
organelles and so the plasma membrane becomes essentially
the only organelle of the lens. This phenomenon makes the
lens one of the best tissues to study the fundamental aspects
of cell differentiation and aging. Our interest in dolichol
originated from the possibility that there could be a connection
between dolichol and cataract, as cataract is an age-related
disease and dolichol is a marker for aging [1]. Moreover,
oxidative stress is the major risk factor for cataract, and
dolichol has been proposed to protect membrane lipids against
oxidative free radical species and it also has ultraviolet (UV)
absorbing properties [9]. Since it has been observed that
dolichol is altered under conditions of oxidative stress [10],
we decided to quantitate dolichol in human lenses with and
without cataract.
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The presence of dolichol in the lens is constitutive, and
hence it may be required in the normal functioning of the lens
fiber cell membrane. In the present study, dolichol levels in
human lenses from different types of cataract were measured.
Further, we also tried to quantitate different dolichol species.
To our knowledge, the present study is the first of its kind to
characterize dolichol species in the human lens and to define
its structural role in the lens in association with its pathological
condition.
METHODS
Collection of human lens samples: Whole lenses (clear) were
collected from cadaver eyeballs from the C. H. Nagri Eye
Bank and Red Cross Society Eye Bank (Ahmedabad, India).
Cataractous nuclei were collected after extracapsular cataract
extraction (ECCE). All the lenses were stored at –50 °C until
use. All the lenses collected from human donor eyes
(postmortem time 4–12 h) were in accordance with the
Declaration of Helsinki. Ethical approval for the use of human
lenses was obtained from the Institutional Ethics Committee
of ICIRC.
Cataract patients between 45 and 70 years with pupils
dilating more than 7 mm and with otherwise normal eyes were
included in the study. Exclusion criteria were diabetes
mellitus, hypertension, glaucoma, shallow anterior chamber,
uveitis, high myopia (axial length >27.0 mm),
pseudoexfoliation, traumatic cataract, subluxated cataract,
previous ocular surgeries, ocular disease, patients on steroids
or immunosuppressive therapy, and those allergic to dilating
drops. All the patients were subjected to a slit-lamp
examination, and the type of cataract was recorded according
to the zone of opacification (LOCs III Classification System
[11]). The grade of cataract was also recorded based on the
degree of hardness using the Emery and Little classification
[12].
Quantification of dolichol:
Extraction of dolichol from the lens—Wet weight of
the lenses was taken, and lenses were stored at −50 °C until
further use. Dolichol extraction was done using the method of
Fedorow et al. [13]. Briefly, the lens tissue supplemented with
an internal standard (0.25 μg of dolichol 13 [Dol-13]) was
homogenized in one volume of methanol and extracted with
five volumes of hexane. The hexane phase was separated after
low speed centrifugation and then dried under nitrogen gas.
The dried lipids were re-dissolved in a known volume of
isopropanol and stored at −50 °C for later HPLC analysis.
HPLC-UV quantification of total dolichol from the
lens lipid extract—All HPLC analysis was performed as
described by Skorupinska-Tudek et al. [14].
Analysis of extracted polyisoprenoids was performed
using a Waters dual pump apparatus (Waters Corporation,
Milford MA),  a Hypersil ODS column (4.6 mm×60 mm,
3 μm; Knauer, Berlin, Germany), a Waters gradient
programmer, and a UV detector set at 210 nm. For elution, a
combination of convex (Waters no. 5, from 0 to 75% B for the
initial 20 min; where solvent A was methanol/water, 9:1, vol/
vol, and solvent B was methanol/propan-2-ol/hexane, 2:1:1,
by volume) and linear (from 75 to 100% B during the
following 10 min) gradients was used; in the last 5 min, re-
equilibration back to 0% B was performed. The solvent flow
rate was 1.5 ml/min. The amount of dolichols was estimated
by comparison with an internal standard of Dol-13. The chain
length and identity of lipids was  confirmed  by applying
qualitative standards extracted from the human liver
containing a mixture of dolichols (Dol-17, -18, -19, -20, and
-21).
Statistical analysis was performed using non-parametric
tests namely the Kruskal–Wallis test and the Mann–Whitney
U tests. A value of p < 0.05 was considered significant.
Chemicals and standards: Organic solvents (HPLC grade)
were purchased from Merck, Ltd. (Mumbai, India) and all the
other chemicals (p.a. grade) were from Sigma-Aldrich (St.
Louis, MO). Standards of dolichol were from the ‘Collection
of Polyprenols’ at the Department of Lipid Biochemistry
(Institute of Biochemistry and Biophysics Polish Academy of
Sciences, Warsaw, Poland).
RESULTS
Table 1 shows the mean and median age of the patients based
on the type of cataract. There was no statistically significant
difference in the age of patients with different types of
cataract. Table 2 shows the dolichol content in the human
lenses of different types of cataract. The level of dolichol in
clear lenses was 1.0±0.43 μg/g (wet weight). The level of
dolichol in lenses with nuclear cataract was 2.54±0.60 μg/g
(wet weight). In those with cortical cataract, it was
0.37±0.06 μg/g (wet weight). Thus, compared to clear lenses,
the dolichol level in eyes with nuclear cataract was 2.5 times
more while in eyes with cortical cataract it was 2.7 times less.
The difference was statistically significant (p=0.004 for
nuclear and p=0.01 for cortical cataract).
Figure 1 shows the molecular species distribution of
standard dolichols extracted from the human liver. Figure 2
shows the molecular species distribution of dolichols in clear
lenses where dolichols ranging from 16 to 20 isoprene units
were detected. The most abundant species is the 19 isoprene
component. Figure 3 shows the molecular species distribution
of dolichols obtained from nuclear cataractous lenses. A slight
shift in the dolichol chain length toward the shorter chain
length was observed in nuclear and cortical cataractous lenses.
The range of species was the same as those for the clear lenses.
However, the most abundant species was Dol-18 instead of
Dol-19. In nuclear cataract, there was a statistically significant
increase in both Dol-18 and Dol-19 concentration compared
to clear lenses (p=0.002 and p=0.01). Figure 4 shows the
comparison of each dolichol species in different types of
cataract using the Mann–Whitney U test. The intact normal
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clear adult human lenses contained between 0.80–1.00 μg/g
(wet weight) of dolichol. Out of this, 15% was Dol-16, 12%
was Dol-17, 21% was Dol-18, 36% was Dol-19, and 17% was
Dol-20. Further, lenses with nuclear cataract contained
2.54 μg/g of dolichol of which 1.5% was Dol-16, 24% was
Dol-17, 34% was Dol-18, 27% was Dol-19, and 12.2% was
Dol-20. Contrary to nuclear cataract, the statistically
significant increase in dolichol content in posterior
subcapsular cataract was due to the significant increase in
Dol-18 and Dol-19 concentration (p=0.03 and p=0.004,
respectively). However, in white mature cataract, there was a
significant increase only in Dol-19 concentration (p=0.004)
and not in any other dolichol species. In cortical cataract, there
was a significant decrease in Dol-19 and Dol-20 content
(p=0.009 and p=0.02, respectively). Similarly, the total
dolichol content decreased in cortical cataract, and the
distribution was 10.8% of Dol-17, 45.9% of Dol-18, 35% of
Dol-19, and 10.8% of Dol-20.
DISCUSSION
In the present study, whole clear lenses from cadaver eyes
used for analysis were considered control samples, and the
nucleus obtained after ECCE was used for lenses from
different types of cataracts. The reason for this is because of
the limitation of the extraction technique. In the clear lens, the
nucleus is not well defined and so cannot be extracted in the
same way as the cataractous nucleus.
The highest dolichol concentration was found in lenses
with nuclear cataract followed by white mature cataract and
posterior subcapsular cataract whereas dolichol concentration
was lower in lenses with cortical cataract when compared to
clear lenses. Nuclear cataract or nuclear sclerosis is
Figure 1. HPLC profile standard dolichol extracted from the human
liver. Profile was obtained by monitering the elute at 210 nm. The
molecular species distribution of standard dolichols show dolichols
ranging from Dol-17 to Dol-22.  The numbers in the chromatogram
identify the six major well defined peaks that are of individual
dolichol species corresponding to Dol-17, Dol-18, Dol-19, Dol-20,
Dol-21, and Dol-22.
TABLE 1. AGE OF THE PATIENTS IN EACH TYPE OF CATARACT.
Cataract type Mean age (years) ±SD
Non-cataractous (n=7) 51±10.1
Nuclear (Type 1; n=6) 62.66±4.36
Cortical (Type 2,3; n=6) 46.3±7.6
Posterior Subcapsular (Type 4; n=6) 57.3±8.6
White mature cataract (n=6) 64.3±7.11
The age of cataract patients included in the study ranged between 45 and 70 years. Values are presented as  mean±SD . There
was no statistically significant difference in the age of patients with different types of cataract.
TABLE 2. DOLICHOL CONCENTRATION IN THE HUMAN LENS.
Cataract type
Dolichol content (μg/g fresh weight)
p valuemean value median value
Control (Non-cataractous) 1.00±0.43 0.99
Nuclear 2.54±0.60 2.53 0.004*
Cortical 0.37±0.060 0.37 0.015*
Posterior Subcapsular 1.42±0.35 1.39 0.13
White mature cataract 1.47±0.36 1.45 0.06
The asterisk indicates that there was a statistically significant difference. There was a marked variability in the concentration
of total dolichol in lens of different types of cataract. The highest levels of dolichol concentration were found in nuclear cataract
followed by posterior subcapsular cataract, and the lowest levels were observed in cortical cataract. The dolichol concentration
in cataractous lenses was statistically significantly higher than the levels in non-cataractous lenses (p<0.01).
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considered to be an age-related cataract, and oxidative stress
is a well established risk factor for age-related cataract. It is
suggested that nuclear cataract is the endpoint of several
events generated due to the effect of oxidative stress, which
includes a decrease in antioxidative enzymes, lipid
peroxidation, and protein precipitation. The effects of
oxidative stress on the dolichol content were recently studied
on isolated rat liver cells by Guarini et al. [10]. Oxidative
stress caused an increase in lipid peroxidation and rapid
degradation of dolichol probably by the same (unknown)
mechanism responsible for the breakdown of ubiquinone
isoprenoid chains. The oxidized derivative of dolichol,
dolichoic acid, was reported in mammalian tissues, i.e., in
bovine thyroid [15] and neuromelanin. In parallel, enzymes
responsible for the conversion of dolichol to dolichal and
dolichoic acid were also described [16,17]. In the present
study, the concentration of Dol-18 increased over that of
Dol-19 in cataractous lenses. However, further work is
required to analyze if dolichoic acid is formed in cataractous
lenses.
Dolichol concentration in lenses with cortical cataract
was 2.7 fold lower than in clear lenses. Despite the lack of
knowledge on the underlying mechanism leading to the
development cortical cataract, epidemiological studies
suggest that prolonged exposure to sunlight [18], UV
irradiation [19], diabetes [20], and vascular diseases [20] play
a vital role in this process. Treatment of UV radiation caused
a dramatic depletion of dolichol levels in a culture model using
liver parenchymal cells [21]. After in vitro UV radiation,
fragmentation of dolichol was observed [21]. Hence, it is not
surprising that the dolichol content is less in cortical cataract.
Whether such a non-enzymatic mechanism is responsible for
the degradation of dolichol in UV-exposed human lenses
remains to be established. While oxidative stress continues to
play an important role in nuclear cataract in general, its role
in the formation of cortical cataract has not been substantiated.
Cortical cataract is shown to be due to a local loss of osmotic
regulation and calcium overload [22]. Hence, there is adequate
evidence showing the differences in etiology for the two types
Figure 2. HPLC profile of total dolichol extracted from clear human
lens. The peaks show the molecular species distribution of dolichols
in normal lenses where dolichols ranging from 17 to 20 isoprene units
were detected. The most abundant species is the Dol-19 component.
of cataracts [22,23]. In contrast, there was an increase in
dolichol content in posterior subcapsular cataract and white
mature cataract, although no shift in the chain length was seen.
In fact, the increase in dolichol levels was mainly due to the
increase in dolichol 19 levels.
What are the consequences of the increased or decreased
concentration of dolichols in human lenses? Since this is the
first report on dolichol concentration, it is difficult to arrive at
any general conclusion. The accumulation of dolichols in
membranes could destabilize them as these compounds are
fusogenic and can alter fluidity, membrane permeability, and
membrane functioning [2]. Oxidation of lenticular
membranes and cytosolic components is believed to lead to
cataractogenesis in humans [23]. Hence, there has been great
interest in the natural antioxidants of lenses and the possibility
of delaying cataract development [24,25]. So far the only
human endogenous lipid antioxidant reported in the lens is
ubiquinone (coenzyme Q) with a concentration of 0.3–
0.4 μg/g [26]. The ubiquinone molecule consists of a
polyisoprene hydrocarbon chain built of 10 isoprene units
attached to a parabenzoquinone ring. Dolichol levels
measured in the lenses in the present study were three times
higher than ubiquinone levels. However, it is unclear whether
increased dolichol levels are observed in nuclear cataract
because of the altered cholesterol synthetic pathway as seen
in cataract formation or if dolichol acts as a free radical
scavenger as postulated earlier [5]. However, the potential
mechanism of dolichol involvement in cataract etiology needs
to be addressed.
The change in the distribution of free dolichol in human
cataract is of interest. In clear lenses, Dol-18, -19, and -20
dominate with Dol-19 exceeding Dol-18 and Dol-20 1.7 and
2.2 fold, respectively. However, in nuclear cataractous lenses,
Dol-18 exceeds Dol-19 and Dol-20 1.2 and 2.8 fold,
respectively. In all the human tissues studied so far, Dol-19
was the predominant species [27]. Thus the lipid distribution
in cataractous lenses seems to have shifted in favor of slightly
Figure 3. HPLC profile of total dolichol extracted from human lens
with nuclear cataract. The peaks show the molecular species
distribution of dolichols. A shift in the dolichol chain length toward
the shorter chain length was observed in nuclear cataractous lenses.
The range of species was the same as those for the clear lenses. The
most abundant species was Dol-18 instead of Dol-19.
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lower lengths and a more narrow distribution (Figure 2). The
dolichol chain length pattern is considered a species specific
marker. It does not vary in different tissues of animals
belonging to the same species [28,29]. The effect of
pathological conditions on the dolichol chain length is not
understood. Eggens et al. [30] noted that the chain length of
the dominating dolichol isolated from an autopsy of human
hepatocarcinoma samples was shorter by one isoprene unit as
compared to that observed in normal liver cells, i.e., there was
a relative increase in the content of Dol-18 and 17 together
with a decrease in the content of Dol-20 and Dol-21. These
observations were explained by the preferential use of
farnesyl diphosphate, a common precursor of cholesterol,
dolichol, and ubiquinone, for the biosynthesis of cholesterol.
In contrast, Sagami et al. [31] proposed that the formation of
the shorter chain length product was due to the limited
concentration of the polymerizing monomeric substrate
isopentenyl diphosphate. In contrast, a shift toward longer
dolichol species has been reported in preneoplastic nodules
[32] in rat liver cells. The mechanism responsible for the
modulation of the product specificity of cis-prenyltransferase,
the enzyme catalyzing the synthesis of the dolichol chain,
remains unclear. In the present study, dolichols in all forms
are higher in cataractous lenses than in the control. Although
we are unable to explain this, we speculate three possibilities:
(1) an increase in the amount of total dolichol by the
preferential use of farnesyl diphosphate, a common precursor
of cholesterol, dolichol and ubiquinone; (2) possible
conversion of dol-19 to the smaller species; and (3)
modulation of the activity of cis-prenyltransferase.
Figure 4. Concentration of each dolichol species in lenses with
different types of cataract. A statistically significant increase in both
Dol-18 and Dol-19 concentrations compared to clear lenses was
found in nuclear cataract and posterior subcapsular cataract. In
contrast, a statistically significant decrease in Dol-19 and Dol-20
content was found in cortical cataract. An asterisk indicates that
p=0.002 when compared to clear lens. The dollar sign ($) denotes
that p=0.015 when compared to clear lens, and a hash mark means
p=0.03 when compared to clear lens.
Dolichol may function in the lens as a free radical
protecting agent and/or a modulator of physicochemical
properties of the membrane [2,33]. The tissue concentration
of dolichol and its derivatives has been investigated in several
pathological conditions, and considerable changes have been
described. The levels of dolichol increased during aging,
cirrhosis, liver cancer, and ceroid lipofuscinosis, e.g., dolichol
levels increased in human and rat tissues upon aging [34]. A
sevenfold increase in dolichol levels was observed in the
lungs, and a 150 fold increase was observed in the pancreas
with age. An age-dependent increase in dolichol concentration
has been documented in many tissues such as the liver, heart,
brain, kidney, etc. [2,33]. On the other hand, no change has
been documented in dolichol levels in tissues like the spleen.
Contrary reports have been published on an increase as well
as a decrease in plasma dolichol concentrations [35]. In the
present study, no obvious correlation was observed between
dolichol levels and the age of the lenses. However, the sample
size was too small to draw a general conclusion.
To our knowledge, there have been no reports on the
presence of dolichol in human lenses, although prenylation of
lens proteins has been reported [36].
The accumulation of dolichol in the lens might possibly
influence the process of glycosylation of proteins since
dolichyl phosphate acts as a cofactor in this process. Although
human tissues possess the appropriate enzymatic machinery,
dolichyl kinase [37], its expression in the lens has not yet been
analyzed.
In general, more than 70% of all the proteins in eukaryotic
cells are predicted to be N-glycosylated [38]. In this regard,
regional differences have been reported in glycoprotein
expression in lens epithelial cells and fibers of chicken lenses
[39]. This indicates that glycoproteins play a role in the
regulation of lens functioning.
The composition of lipids in lenses has been extensively
studied [40]. Lens membranes have the highest cholesterol
content of any known membrane, but there appears to be no
clear relationship between lens cholesterol content and human
senile cataract [41]. Inherited defects in enzymes involved in
cholesterol metabolism and the use of drugs, which inhibit
lens cholesterol biosynthesis, can be associated with cataract
formation in animals and humans [41]. Out of the six inborn
defects of cholesterol biosynthesis described in humans, three
defects namely mevalonic aciduria [42], Smith-Lemli-Opitz
syndrome [43], and X-linked dominant chondroplasia
punctata 2 [44] have cataract as complications. The cause of
cataract in these diseases was postulated to be due to the
decrease in cholesterol levels in lenses. Dolichol, however,
has not been analyzed in such conditions.
Based on all these facts and hypotheses, it would be
interesting to analyze the differences in glycosylated proteins
of lenses. Furthermore, it would be interesting to estimate the
levels of key enzymes of the mevalonate pathway, e.g., 3-
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hydroxy-3-methyl-glutaryl-CoA (HMG CoA) reductase, cis-
prenyl transferase, etc.
In conclusion, a significant difference in dolichol
concentration was observed between the different types of
cataract with the highest concentration in lenses with nuclear
cataract and the lowest in cortical cataract, suggesting that
dolichol and other isoprenoids may be associated with
cataractogenesis.
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